Events
-
-
Training | The ABCs of Hepatitis (NYS Health Dept)
This 90-minute webinar will cover the epidemiology, modes of transmission, prevention techniques, and treatment of Hep A, B, and C.
-
Hep BLiverConnect ECHO (American Liver Foundation)
LiverConnect is a video-teleconference program, which includes a didactic presentation on liver disease or related topics.
-
Hep C Medical Care & Treatment Update for Peer Workers – Part 3 (NYS Health Dept)
This webinar will explore practical strategies that peers can draw on to support clients’ engagement in Hep C medical care and treatment.
-
Hep C Stigma: From Clinic to the Streets (Hep C Mentor & Support Group)
Zoom Webinar NYHep C Stigma: From the Clinic to the Streets on April 22 from 5 to 6 PM.
-
Training | From Stigma to Affirmation (NYS Health Dept)
This webinar will define stigma, raise awareness about the impact of stigma and provide concrete skills and resources for providing affirming services.
-
Hep B in Southern Africa: Epidemiology, Integration, and the Role of Advocates in Civil Society (Hep B Foundation)
Zoom MeetingThis webinar explores the epidemiology, integration and the role of advocates in addressing Hep B in Southern Africa.
-
Hep C Intervention Implementation Symposium (International Network on Health and Hepatitis in Substance Users)
This symposium will cover practical aspects of implementing innovative interventions for Hep C.
-
Virtual Advocacy Day Training (Hep B United)
Zoom MeetingLearn how to discuss congressional asks, and get tips and tricks for conducting an Advocacy Day .
-
Viral Hepatitis Diagnostics Working Group Call (National Viral Hepatitis Roundtable)
Zoom MeetingThe purpose of this meeting is to bring the voice of people with lived experience to the table in developing strategies, activities, and tactics to achieve advocacy goals.
-
CME/CNE/CEU | Hep C Treatment in People Who Inject Drugs (Empire Liver Foundation)
Zoom Webinar NYTo discuss and navigate Hep C screening and management methods presented by liver disease specialists to reduce Hep C prevalence.
